Assessment of coronary flow reserve by Doppler flow wIre in patients with acute coronary syndrome undergoing percutaneous coronary intervention: differences between the LoAding dose of Ticagrelor versus prasugrEl (DILATE): study protocol for a randomized controlled trial

[1]  M. Valgimigli,et al.  Reducing Microvascular Dysfunction in Revascularized Patients with ST-Elevation Myocardial Infarction by Off-Target Properties of Ticagrelor versus Prasugrel. Rationale and Design of the REDUCE-MVI Study , 2016, Journal of Cardiovascular Translational Research.

[2]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[3]  Volker Klauss,et al.  Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial , 2015, The Lancet.

[4]  Helmut Baumgartner,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  K. Lackner,et al.  Effects of clopidogrel, prasugrel and ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting for an acute coronary syndrome. A randomised, prospective, controlled study , 2014, BMJ Open.

[6]  Jeroen J. Bax,et al.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.

[7]  I. Xanthopoulou,et al.  Differential Effect of Ticagrelor Versus Prasugrel on Coronary Blood Flow Velocity in Patients With Non–ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Exploratory Study , 2013, Circulation. Cardiovascular interventions.

[8]  G. Brandrup-Wognsen,et al.  Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans. , 2013, Journal of the American College of Cardiology.

[9]  A. Waller,et al.  Fractional flow reserve (FFR): changing the practice of interventional cardiology. , 2012, Minerva cardioangiologica.

[10]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[11]  J. Sidaway,et al.  Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model , 2012, Journal of cardiovascular pharmacology and therapeutics.

[12]  K. Ley,et al.  Regulation of Neutrophil Function by Adenosine , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[13]  B. Olde,et al.  Ticagrelor induces adenosine triphosphate release from human red blood cells. , 2012, Biochemical and biophysical research communications.

[14]  P. Gurbel,et al.  Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses , 2011, Journal of thrombosis and haemostasis : JTH.

[15]  D. Schneider.  Mechanisms potentially contributing to the reduction in mortality associated with ticagrelor therapy. , 2011, Journal of the American College of Cardiology.

[16]  V. Serebruany.  Adenosine release: a potential explanation for the benefits of ticagrelor in the PLATelet inhibition and clinical outcomes trial? , 2011, American heart journal.

[17]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[18]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.